scispace - formally typeset
Open AccessJournal ArticleDOI

Child–Parent Familial Hypercholesterolemia Screening in Primary Care

Reads0
Chats0
TLDR
Child-parent screening was feasible in primary care practices at routine child immunization visits and 8 persons were identified as having positive screening results for familial hypercholesterolemia and were consequently at high risk for cardiovascular disease.
Abstract
BackgroundChild–parent screening for familial hypercholesterolemia has been proposed to identify persons at high risk for inherited premature cardiovascular disease. We assessed the efficacy and feasibility of such screening in primary care practice. MethodsWe obtained capillary blood samples to measure cholesterol levels and to test for familial hypercholesterolemia mutations in 10,095 children 1 to 2 years of age during routine immunization visits. Children were considered to have positive screening results for familial hypercholesterolemia if their cholesterol level was elevated and they had either a familial hypercholesterolemia mutation or a repeat elevated cholesterol level 3 months later. A parent of each child with a positive screening result for familial hypercholesterolemia was considered to have a positive screening result for familial hypercholesterolemia if he or she had the same mutation as the child or, if no mutations were identified, had the higher cholesterol level of the two parents. Re...

read more

Citations
More filters
Journal ArticleDOI

Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.

TL;DR: The Expert Consensus Panel recommends that FH genetic testing become the standard of care for patients with definite or probable FH, as well as for their at-risk relatives, and more accurate risk stratification.
Journal ArticleDOI

Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.

TL;DR: FH prevalence in the general population was similar using genetic versus clinical diagnoses, and FH prevalence is 10-fold higher among those with IHD, 20-fold Higher among thoseWith premature IHD and 23-foldHigher among thosewith severe hypercholesterolemia.
Journal ArticleDOI

Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis.

TL;DR: The authors' systematic review suggests that FH is a common disorder, affecting 1 in 250 individuals, and underscore the need for early detection and management to decrease CVD risk.
References
More filters
Journal ArticleDOI

Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.

TL;DR: The lack of clinical expression in obligate FH heterozygotes is not due to unusually "mild" mutations in the LDL-receptor gene, and other genetic or environmental factors must therefore be important in determining phenotypic expression.
Journal ArticleDOI

Child-parent screening for familial hypercholesterolaemia: screening strategy based on a meta-analysis.

TL;DR: An ambitious meta-analysis of 13 independent studies, including a total of 1907 people with FH and 16,221 controls, presents clear age-related differences in the ability to distinguish between affected and unaffected individuals based upon serum cholesterol measurements.
Journal ArticleDOI

Discriminative Ability of LDL-Cholesterol to Identify Patients With Familial Hypercholesterolemia A Cross-Sectional Study in 26 406 Individuals Tested for Genetic FH

TL;DR: The overlap in terms of LDL-C levels between those with molecularly proven FH and unaffected relatives is to a large extent because of the high prevalence of modestly severe LDL-receptor mutations in the Netherlands.
Journal ArticleDOI

Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.

TL;DR: The results indicate that FH is more genetically diverse in Ontario than in Quebec, and are consistent with findings from investigations of the LDLR in FH conducted in other countries, in which PCR‐based, exon‐by‐exon sequencing uncovers small mutations in about half of the subjects screened.
Related Papers (5)